Platelet-rich plasma (PRP) local injection for female sexual dysfunction

• Register: ANZCTR
• Last refreshed on: 26 August 2019
• Main ID: ACTRN12617000524392
• Date of registration: 10/04/2017
• Prospective Registration: Yes
• Primary sponsor: DOAA MOHAMED SALEH
• Public title: Platelet-rich plasma (PRP) local injection for female sexual dysfunction
• Scientific title: Platelet- rich plasma (PRP) local injection for female sexual dysfunction
• Date of first enrolment: 20/04/2017
• Target sample size: 40
• Recruitment status: Not yet recruiting
• URL: https://anzctr.org.au/ACTRN12617000524392.aspx
• Study type: Interventional
• Study design: Purpose: Treatment; Allocation: Non-randomised trial; Assignment: Single group;Type of endpoint: Efficacy;
• Phase: Not Applicable

Countries of recruitment

Egypt

Contacts

• Name: A/Prof nahed ezzat

• Name: Prof taiseer marouf

Key inclusion & exclusion criteria

Inclusion criteria: sexually active females 18-60 years complaining of sexual dysfunction.

Exclusion criteria: 1- psychological or mental illness.
2- male partner erectile dysfunction.
3- diabetic patients


Age minimum: 18 Years
Age maximum: 60 Years
Gender: Females

Health Condition(s) or Problem(s) studied

Sexual dysfunction;
Sexual dysfunction

Reproductive Health and Childbirth - Other reproductive health and childbirth disorders

Intervention(s)

A small sample of blood (5ml) is withdrawn from the patient, then spun in a centrifuge to separate the blood into layers. The platelet-rich plasma layer is carefully extracted, then injected back into the anterior and posterior vaginal wall, G-spot and clitoris. the procedure will take about 10 minutes after local anaesthetic cream application.procedure will be done in the outpatient clinic by gynaecology specialist with minimum 3 years experience.patients will receive four times injections 2weeks a part.they will be evaluated by FSFI questionnaire after 2 months.

Primary Outcome(s)

change in sexual function accessed by FSFIq before and after the procedure.[2 months after PRP injection]

Secondary Outcome(s)

2-change in urinary incontinence in patients complaining of incontinence.
will be assessed by ICIQ short form questionnaire.[2 months after PRP injection]

1-The incidence of vaginal infection assessed by self-report.
[2 months after PRP injection.]

Secondary ID(s)

none

Source(s) of Monetary Support

AL ZAHRAA UNIVERSITY HOSPITAL

Secondary Sponsor(s)

TAISEER MAROUF

Ethics review

Status: Not required
Approval date:
Contact:

Northern A Health and Disability Ethics Committee